The Delhi High Court has temporarily halted the sale of Dabur's Cool King oil due to a packaging resemblance to Emami's Navratna Oil, ruling in favor of Emami's claim that Dabur copied their design. Despite Dabur's assertions of differentiation through branding, the court found potential consumer confusion to be a concern.

According to a discussion in the Awaaz Boardroom, Emami's Q4 results were subpar due to some key issues pointed out by CEO N.H. Bansali on CNBC-Awaaz. The CEO provided insights into the factors affecting Emami's performance during this period.

Emami anticipates growth by 2027, despite facing margin issues in the talc category. They expect increased demand during the summer season to drive this growth, despite these hurdles.

Elara Capital maintains a positive outlook for Emami, recommending a buy, albeit with a revised price target of ₹550.

Today, Sun Pharma, Hindalco, Eicher Motors, Torrent Pharma, and NTPC Green are set to release their Q4 results, with ITC, LIC, GAIL, Emami, Max Health, JSW Cement, Va Tech, and 3M India also under the spotlight for their financial performances. Investors will closely monitor these companies' results to gauge their performance in the recent quarter.

Emami anticipates a significant growth of over 10% for both Navratna and Dermicool product lines by the first half of FY27, with international business predicted to surge in double-digits from Q2 FY27 onwards.

Emami's Q4 earnings saw a 12% decrease from last year, reporting net profit of INR 143 crores on lower revenues of INR 925 crores. EBITDA also dropped by 15%, with margins shrinking to 20.2% compared to last year's 23%.

Emami experiences a 3% sales drop due to unseasonal rains affecting its summer portfolio, but excluding summer items, the company still manages an 11% growth. The Pain Management, Kesh King, and Healthcare segments all show positive growth of 11%, 14%, and 7%.

Emami's shares have dropped due to missing Q4 earnings targets and a lackluster performance in their summer product offerings.

Emami experiences a decline in its Q4 net profit, dropping from ₹1.62B to ₹1.4B compared to the previous year.

Emami struggles with single-digit revenue growth due to decreased consumer demand and challenging pricing conditions.

FMCG stocks such as Marico, Dabur, Nestle have recovered and boosted the Nifty FMCG index by 7% over the past month. Notably, Dabur and HUL have increased their product prices. Simultaneously, stocks like ITC and Emami find themselves at decade-low valuation levels.

Emami Limited has decided to invest INR 321 crores to acquire a 60% share in IncNut Digital, bolstering its position in the beauty and personal care sector. This strategic move is intended to broaden Emami's reach within these segments.

The election outcomes in five states could potentially influence the share prices of companies such as Sun TV, Bandhan Bank, CESC, and Emami, according to analysis by Ashish 4vedi. This suggests potential market shifts linked to government changes.

The victory of BJP in West Bengal has led to a surge in shares of companies such as Bandhan Bank, Emami, and RP Sanjiv Goenka firms. However, market analysts advise caution, suggesting the rally may be driven by sentiment rather than substantial earnings growth, stressing the importance of effective policy execution for continued growth.

Escalating oil prices, driven by geopolitical tensions in Iran, are putting a strain on the profit margins of consumer goods companies like Emami, Dabur, and ITC. The rise in costs for packaging, chemicals, and transportation is squeezing their earnings due to increased input costs linked to crude oil.

Today, shares of companies such as HUL, Dabur, and Emami have seen a surge of up to 6%, with the FMCG sector experiencing a growth of 2.3% on Nifty. This upward trend can be attributed to reduced costs, stable consumer demand, and their defensive appeal, despite ongoing challenges with input costs.

Tata Steel faces a hefty Rs 1,755 crore mining claim, potentially impacting its finances significantly. Meanwhile, Emami is set to acquire a substantial 73.5% stake in Axiom Ayurveda, and Shree Cement plans to invest Rs 1,800 crore in a new plant in Meghalaya.

Emami expands its portfolio with the purchase of Axiom Ayurveda for INR 200 crores, marking a significant step in the ayurvedic sector. Meanwhile, Tata Motors reports a 14.5% drop in Q4 wholesales and RVNL secures an order worth INR 242 crore. Elsewhere, RBL Bank experiences a 24% rise in YoY business growth, while PNB's global business growth is at 10.8% with a CASA ratio of 73.7%. The RBI approves the sale of 74% stake to Emirates NBD.

Major FMCG companies such as Reliance Retail, Emami, and Dabur are turning to Ayurveda startups to drive growth, given the market's current sluggishness. These firms are increasingly focusing on regional and specialized Ayurvedic brands to capitalize on growing consumer interest in traditional health products.

Emami Ltd has announced the purchase of a majority stake in Axiom Ayurveda for INR 200 crores, aiming to fully own the company by June 2026. Axiom Ayurveda, a FMCG company specializing in healthy beverages, is expected to boost Emami's growth in the consumer goods sector.